Table 1

Main characteristics of these studies on the associations between XPC Lys939Gln polymorphism and bladder cancer risk
First author Year Country Ethnicity Study type Genotype method Sample size PHWE
Case Control
Sanyal et al. 2004 Sweden Caucasian PB PCR-RFLP 309 246 0.294
Sak et al. 2005 England Caucasian HB TaqMan 532 561 0.191
Garcia-Closas et al. 2006 Spain Caucasian HB TaqMan 1137 1138 0.470
Wu et al. 2006 USA Caucasian HB TaqMan 606 596 0.744
Zhu et al. 2007 USA Caucasian HB Taqman 550 554 0.668
Fontana et al. 2008 French Caucasian HB TaqMan 51 45 0.456
de Verdier et al. 2010 Sweden Caucasian PB PCR-RFLP 305 328 0.147
Gangwar et al. 2010 India Asian HB PCR-RFLP 208 245 0.054
Rouissi et al.1 2011 Tunisia African HB PCR-RFLP 193 193 0.537
Rouissi et al.2 2011 Tunisia African HB PCR-RFLP 125 125 0.449
Mittal et al. 2012 India Asian PB PCR-RFLP 212 250 0.073
Liu et al. 2012 China Asian HB PCR-RFLP 600 609 0.824

PB Population-Based Study, HB Hospital-Based Study, PHWE P value of Hardy–Weinberg equilibrium. PCR-RFLP Polymorphism Chain Reaction- Restriction Fragment Length Polymorphism. 1,2 Different studies.

Dou et al.

Dou et al. Diagnostic Pathology 2013 8:112   doi:10.1186/1746-1596-8-112

Open Data